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doi:10.1Objective: We report the long-term results of left ventricular surgical restoration in which 2 different strategies
were used, which had restoration of ventricular volume or ventricular shape as their target.
Methods: From 1988 to 2008, 308 patients with anterior scars underwent elective left ventricular surgical
restoration. Before 2002, a Dor procedure was performed in 107 cases to reduce left ventricular volume (group
V); from 1998 to 2001, a Guilmet procedure was performed in 32 patients to rebuild a left ventricular conical
shape (group S). From 2002, 169 patients (group S) underwent left ventricular surgical restoration to reshape a con-
ical left ventricle by means of the Dor procedure (n¼ 29, septoapical scars) or septal reshaping (n¼ 140, when the
septum was more involved than the anterior wall). The 2 groups were similar for all features but age, mitral
regurgitation grade, mitral valve surgery rate (higher in group S), and ejection fraction (higher in group V).
Results: Early mortality was 7.8% (11.2% in group V vs 6.0% in group S, P ¼ .102). Logistic regression
showed that volume reduction was significantly related to higher early mortality. Five-year cardiac survival,
cardiac event–free survival, and event-free survival were higher in group S. Cox analysis showed that the choice
of volume reduction provided lower survival (hazard ratio, 2.1), cardiac survival (hazard ratio, 3.0), cardiac
event–free survival (hazard ratio, 2.7), and event-free survival (hazard ratio, 2.2). When 30-day events were
excluded, volume reduction was still a risk factor for cardiac event–free survival (hazard ratio, 2.2).
Conclusions: When the main target of left ventricular surgical restoration is left ventricular reshaping rather
than left ventricular volume reduction, early and late outcomes seem to improve. (J Thorac Cardiovasc Surg
2010;139:1123-30)Earn CME credits at
http://cme.ctsnetjournals.org
Surgical treatment of anteroseptal scars has been and still is
a challenging task for cardiac surgeons. Most patients are in
cardiac failure, and the infarcted areas can include different
parts of the septum and anterior wall. The core problem of
ischemic congestive heart failure is the undue demand put
on the residual viable left ventricular (LV) myocardium.1
Surgical techniques applied to correct the mismatch between
contractile and asynergic areas are different. The most pop-
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The Journal of Thoracic and Carand still is used worldwide. This technique is addressed to
the recovery of a predictable volume but not to the rebuild-
ing of a physiologic conical shape. Another French surgeon,
Daniel Guilmet, described in the 1980s a technique (over-
coat technique) that led to a conical shape of the heart.4
We revisited the original Guilmet technique at the end of
the 1990s, using some modifications but maintaining the
same concept.5 In 2002, we finally applied, in all our pa-
tients, techniques finalized to recover a conical shape, septal
reshaping,6 evolution of the Guilmet technique, and the Dor
operation only in the presence of septoapical scars.
The results of the Surgical Treatment for Ischemic Heart
Failure (STICH) trial, hypothesis 2, which were recently pub-
lished,7 were not in favor of adding left ventricular surgical re-
modeling (LVSR) to coronary artery bypass grafting (CABG).
However, this study was focused on recovery of volume and
not of shape. Furthermore, patients were screened on ejection
fraction (EF) and not on ventricular volumes. The purpose of
our study is to report the long-term results of 2 different strat-
egies that had, as their targets, restoration of ventricular vol-
ume, as in the STICH trial, or of ventricular shape.MATERIALS AND METHODS
Patient Population
From January 1988 to February 2008, 308 patients underwent first-time
surgical exclusion of anteroseptal scars. Two groups could be identified. Thediovascular Surgery c Volume 139, Number 5 1123
Abbreviations and Acronyms
AMI ¼ acute myocardial infarction
CABG ¼ coronary artery bypass grafting
EF ¼ ejection fraction
LV ¼ left ventricular
LVSR ¼ left ventricular surgical remodeling
MR ¼ mitral regurgitation
NYHA ¼ New York Heart Association
STICH ¼ Surgical Treatment for Ischemic Heart
Failure
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Dfirst includes patients in whom the target was LV volume (group V; n¼ 107
patients who had the classic Dor procedure between 1988 and 2001). The
second group included patients in whom the target was recovery of LV
shape (group S, n ¼ 201, 32 patients who had the Guilmet procedure be-
tween 1998 and 2001 and 169 who underwent septal reshaping [n ¼ 140]
or the septoapical Dor procedure [n ¼ 29] between 2002 and February
2008). Retrospective analysis of our database was approved by the institu-
tional review board, which waived patient consent. Table 1 shows some
patient characteristics. Echocardiographic transthoracic assessment was per-
formed preoperatively, at discharge from the hospital, and during follow-up.
Echocardiographic Assessment
In all patients the following data were evaluated: LV systolic and dia-
stolic diameters, LV indexed end-systolic and end-diastolic volumes, EF,
and the diastolic sphericity index (transverse diameter/longitudinal diame-
ter). Evaluation of mitral regurgitation (MR) grade integrated multiple pa-
rameters (eg, jet area, jet area/left atrial area ratio, number and direction
of jets, and vena contracta). MR was divided into 4 grades: mild (1þ), mod-
erate (2þ), moderate to severe (3þ), and severe (4þ). Table 1 shows some
echocardiographic data from the study groups.
Surgical Techniques
The Dor procedure (group V) was performed as described by Dor and
colleagues.1 A rubber balloon inflated with 50 to 60 mL/m2 saline was
used in one third of cases (n¼ 37). The modified Guilmet procedure (group
S) included a suture of the scarred anterior wall to the scarred septum with
interrupted U sutures.5 Septal reshaping (group S) was used when the sep-
tum was more involved than the anterior wall (Figure 1, A).6 In this proce-
dure the length of the patch depends on the distance between the highest
point and the new apex; its height is related to the LV diastolic volume. If
less than 80 mL/m2, the length/height ratio is 2:1; if 80 mL/m2 or greater,
the ratio is 3:1; and in case of restrictive diastolic dysfunction, the ratio is
3:1 as well. To be sure that the longitudinal diameter is long enough, the po-
sition of the new apex has to be roughly 5 cm from the base of the papillary
muscles and, for this purpose, can be positioned in the apical scar. The sep-
toapical Dor procedure (group S) was used only in case of scars that in-
volved the distal portion of the septum and the apex (Figure 1, B). A
small patch was used in 11 cases, and in the remaining patients no patch
was used. Again, the purse string was positioned roughly 5 cm from the
base of the papillary muscles. Mitral valve surgery was performed in 114
(37.0%) cases, 90 (45.8%) in group S and 24 (22.4%) in group V
(P< .001). In 12 (3.9%) cases a mitral prosthesis was inserted inside the
native mitral valve because the coaptation depth was greater than 10
mm,8 whereas in 102 (33.1%) cases the mitral valve was repaired.
Definition of Terms
Operative mortality was defined as any death occurring in the first 30
days from surgical intervention and late mortality as anymortality occurring1124 The Journal of Thoracic and Cardiovascular Surduring follow-up. Cardiac death was defined as any death of cardiac cause;
patients who experienced sudden or unexplained death were considered as
having cardiac death. Cardiac events were defined as cardiac death, cardiac
reoperation, hospitalization for heart failure, heart transplantation, and New
York Heart Association (NYHA) class III/IV. Any event was defined by the
same events, including all deaths of any cause.
Follow-up
All patients were clinically followed up in our outpatient clinic 3, 6, and
12 months after surgical intervention and thereafter at yearly intervals. The
most recent information was obtained by calling the patient or the referring
cardiologists. Follow-up was 100% complete. The end of follow-up was
June 2008.
Statistical Analysis
Results are expressed as means  standard deviations and median
values. Categorical variables were reported as counts and percentages. Dif-
ferences between the 2 groups were evaluated by means of independent t
tests (continuous variables) and c2 tests (categorical variables). A saturated
logistic regression model (Appendix 1) has been used to obtain the propen-
sity score by using groupA as a reference (goodness-of-fit c-statistic¼ 0.81).
Different parametric models (exponential, Weibull, and Gompertz) were
used to assess changing of hazard function across time; in all cases the haz-
ard risk peaked at 1 month (early phase). Hence risk factors for early mor-
tality were investigated by means of stepwise binary logistic regression,
entering into the initial model all variables reported in Appendix 2. The final
model was validated bootstrapping 1000 samples, and the results were re-
ported as b coefficient  standard errors and P values. Five-year survival
curves were obtained by using the Kaplan–Meier method; significant differ-
ence was evaluated with the log-rank test. Time-to-event analysis was per-
formed by using a multivariable Cox proportional hazard regression (see
stepwise logistic regression). The results of Cox analysis were reported as
b coefficients  standard errors and P values. Because surgical experience
increased over time during the study period, to eliminate the confounding
effect of different early mortality, the events occurring during the first 30
days were eliminated, and the outcome analysis was repeated. Changes in
LV volume, sphericity index, and EF from the preoperative period to the fol-
low-up period have been evaluated by means of longitudinal linear mixed-
model regression for repeated measurements. Changes in NYHA class and
MR grade across time have been evaluated by means of longitudinal ordinal
logistic regression for repeated measurements.9 The propensity score was
forced in all the regression analyses to adjust all the models for preoperative
and operative differences.10 Validation of the models was performed
in 1000 bootstrap samples.11 SPSS software (SPSS, Inc, Chicago, Ill) was
used.RESULTS
Table 1 shows the clinical, echocardiographic, and surgi-
cal data of the 2 groups. All patients had a Q-wave antero-
septal myocardial infarction of differing extent. Operative
mortality was 7.8%, higher in group V (11.2% vs 6.0%)
but not significantly so (P ¼ .102). Causes of death were
cardiac in 19 cases and noncardiac in the remaining 5 cases.
Results of stepwise logistic regression are reported in
Table 2.
Five-year freedom from death of any cause was 77.6%
2.5% (72.9%  4.3% in group V vs 81.0%  2.9% in
group S, P ¼ .140), freedom from cardiac death was
82.5%  2.3% (76.3%  4.1% vs 86.6%  2.6%,
P ¼ .032; Figure 2, A), freedom from any cardiac eventgery c May 2010
FIGURE 1. Transthoracic echocardiographic analysis, 4 chambers. A, The
scar involves the septum and the apex. B, The scar is limited to the septoap-
ical portion of the left ventricle.
TABLE 1. Clinical, echocardiographic, and surgical data
Group V (n ¼ 107) Group S (n ¼ 201) P value
Age (y) 62  10 66  10 .001
Female sex 20 (19%) 32 (16%) .536
Angina 57 (53%) 108 (54%) .957
NYHA class .192
II 49 (46%) 72 (36%)
III 42 (39%) 98 (49%)
IV 16 (15%) 31 (15%)
EDV (mL/m2) 112  42 111  38 .811
ESV (mL/m2) 73  33 75  33 .716
EF (%) 39  10 35  9 <.001
MR (0–4þ) <.001
0 56 (53%) 47 (23%)
1þ 24 (22%) 55 (27%)
2þ 11 (10%) 56 (26%)
3þ 14 (13%) 19 (10%)
4þ 2 (2%) 27 (14%)
TR (1þ–4þ) <.001
0 87 (81%) 106 (53%)
1þ 16 (15%) 60 (30%)
2þ 2 (2%) 24 (12%)
3þ 2 (2%) 9 (4%)
4þ 0 2 (1%)
sPAP (mm Hg) 35  11 40  12 <.001
Akinesia/dyskinesia 32/75 148/53 <.001
LVS
Dor 107 (100%) 29 (14.4%)
Guilmet – 32 (15.9%)
SR – 140 (69.7%)
CABG 97 (90.7%) 148 (73.6%) .008
MVS 24 (22.4%) 90 (45.8%) <.001
TVS 4 (3.7%) 24 (11.9%) .056
NYHA, New York Heart Association; EDV, end-diastolic volume; ESV, end-systolic
volume; EF, ejection fraction; MR, mitral regurgitation; TR, tricuspid regurgitation,
sPAP, systolic pulmonary artery pressure; LVS, left ventricular surgery; SR, septal re-
shaping; CABG, coronary artery bypass grafting;MVS, mitral valve surgery; TVS, tri-
cuspid valve surgery.
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Dwas 72.3%  2.8% (63.9%  4.7% vs 77.9%  3.3%,
P ¼ .011; Figure 2, B), and freedom from any event was
68.3%  2.8% (61.7%  4.7% vs 72.7%  3.5%,
P¼ .052). After a mean of 46 43 months, 58 (18.8%) pa-
tients died (28 in group V and 30 in group S) of cardiac
causes in 44 cases and noncardiac causes in 14 cases. During
the follow-up period, 6 patients underwent heart transplanta-
tion after a mean of 25  18 months; other cardiac reopera-
tions were performed in 5 patients (reoperation for
recurrence of MR in 1, reoperation to relieve untreated
MR in 3, and implantation of a ventricular assist device in
1). Hospitalization for heart failure occurred in 48 patients
(19 in group S and 29 in group V). Cox analysis, adjusted
for propensity score, showed that the choice of volume
rather than shape was a risk factor for late death of any cause,
cardiac death, a cardiac event, and any event (Table 2). Ex-
cluding first-month events, freedom from death of any cause
was 84.2% (82.1% in group V vs 86.2% in group S,The Journal of Thoracic and CarP ¼ .528), freedom from cardiac death was 87.9%
(85.1% in group V vs 90.2% in group S, P¼ .300), freedom
from cardiac events was 77.1% (71.2% in group V vs
81.1% in group S, P ¼ .039), and freedom from any event
was 77.1% (69.5% in group V vs 77.4% in group S,
P ¼ .211). Cox analysis, adjusted for age, EF, and mitral
valve surgery, confirmed that the choice of volume rather
than the shape was a risk factor for freedom from cardiac
events (hazard ratio, 2.2; 95% CI, 1.2–3.8; P ¼ .007).
At the end of the follow-up period, 222 patients survived,
with amean follow-up of 77 50months. Among them, 190
(85.6%) were in NYHA class I or II (77.6% in group V and
89.1% in group S). LV reshaping rather than volume reduc-
tion was associated with NYHA class improving across time
(coefficient,0.82  0.25; P ¼ .001); patients with lower
preoperative NYHA class showed higher probability to re-
main unchanged or improved (0.34  0.13, P ¼ .007).
A postoperative echocardiogram was obtained in 125 pa-
tients within 10 years from surgical intervention (Table 3).
The choice of ventricular reshaping rather than reduction
(b coefficient  standard error, 14.8  7.7; P ¼ .020) and
lower preoperative EF (b coefficient  standard error,0.6diovascular Surgery c Volume 139, Number 5 1125
FIGURE 2. Kaplan–Meier curves: 5-year freedom from cardiac death (A)
and freedom from cardiac events (B). The solid line represents group S, and
the dashed line represents group V. Patients at risk and 95% confidence
limits are also reported.
TABLE 2. Stepwise logistic regression and Cox analysis, adjusted for
propensity score
b coefficient ± SE P value
30-d mortality
LV volume reduction 1.1  0.5 .038
MVS 1.2  0.5 .019
Age 0.07  0.03 .032
NYHA class 1.1  0.4 .001
5-y any death
LV volume reduction 0.9  0.3 .003
MVS 1.1  0.3 .001
5-y cardiac death
LV volume reduction 1.0  0.3 .003
MVS 1.3  0.3 <.001
5-y cardiac event
LV volume reduction 1.0  0.3 .001
MVS 1.3  0.3 <.001
5-y any event
LV volume reduction 0.9  0.3 .001
MVS 1.1  0.2 <.001
SE, Standard error; LV, left ventricular;MVS, mitral valve surgery; NYHA, New York
Heart Association.
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D 0.09, P< .001) were found to be associated with EF im-
proving across time. No factors were found to be associated
with LV volume increase, sphericity index improvement,
and MR impairment across time.DISCUSSION
The main findings of this study were the following: (1)
long-term outcome after LVSR is good, independently
from the surgical technique used, and (2) when shape, and
not volume, is the goal of LVSR, 5-year results are uni-
formly better. The evolution of surgical techniques for
LVSR is still in progress. Since the early 1980s, Dor and col-
leagues2,3 described a technique that deeply influenced the
history of treatment of postischemic congestive heart failure.
With some modifications, it is still a standard of care in this
field. Menicanti and coworkers12 introduced the use of
a shaper to the classic Dor technique to change the philoso-1126 The Journal of Thoracic and Cardiovascular Surphy from the pure search for an adequate volume to the re-
covery of a cavity that is as conical as possible. This goal
was also the purpose of the overcoat technique, described
by Guilmet and associates in 1984,4 which elegantly rebuilt
a conical cavity by suturing the anterior wall directly to the
scarred septum. Need for a more physiologic shape goes to-
gether with the changing pattern of septoapical scars. In the
past, dyskinetic areas and dilation were predominant, and
volume reduction was relatively easy to perform. More re-
cently, akinesia became the most diffuse morphologic as-
pect. In our experience akinetic areas are present in more
than 70% of the patients who undergo LVR. However, these
patients present worse hemodynamic parameters with lower
LV compliance. Reduction of distensibility increases the
end-diastolic pressures (and, consequently, the pulmonary
pressures) and affects the remote zones earlier than in pa-
tients with dyskinetic areas. When progressive dilation of
the uninvolved zone becomes predominant and dilated car-
diomyopathy occurs, medical treatment and surgical op-
tions, except for heart transplantation, become ineffective
and temporary.13 The extent of the dilation is often not uni-
form. The involvement of the septum and anterior free wall
is often different because of the anatomy of the branches of
the left anterior descending coronary artery. Diagonal
branches originate often at 45; as a consequence, the in-
volvement of the anterior free wall is triangular, with the
apex in the upper portion. Septal branches originate often
at 70 to 90; as a consequence, the involvement of the sep-
tum starts as high as the anterior free wall but is deeper than
it. The septum then bulges toward the right ventricle, mini-
mizing the external dilation (Figure 1, A). This anatomic as-
pect has become frequent (82.8% of the cases since 2002),gery c May 2010
TABLE 3. Echocardiographic results
All Group V Group S
Pre (n ¼ 125) Post (n ¼ 125) Pre (n ¼ 44) Post (n ¼ 44) Pre (n ¼ 81) Post (n ¼ 81)
EDV (mL/m2) 110  36 86  27 105  34 88  29 112  37 86  26
EDV D%* 24 (37/11) 20 (7/57) 28 (35/0)
ESV (mL/m2) 74  34 52  22 67  28 52  19 76  35 53  22
ESV D%* 24 (50/0) 18 (56/10) 30 (48/0)
EF (%) 36  11 41  11 39  11 41  10 33  10 41  12
EF D%* 16.1 (2.9/35.9) 7.8 (9.5/23.6) 17.1 (0/42.4)
SI 0.69  0.10 0.71  0.13 0.69  0.10 0.75  0.13 0.69  0.10 0.69  0.13
MR 1.5  1.2 0.7  0.7 1.0  0.9 0.6  0.6 1.8  1.1 0.7  0.6
Follow-up (mo) 47  29 (12–110) 50  32 (16–110) 46  28 (12–107)
Pre, Preoperative; Post, postoperative; EDV, end-diastolic volume; ESV, end-systolic volume; EF, ejection fraction; SI, sphericity index; MR, mitral regurgitation. *Data are ex-
pressed as median values and quartiles.
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2004, is to address the correction mainly to the septum,
which is rebuilt in such a way to be moved anteriorly; the
longitudinal axis is maintained as long as possible to main-
tain a conical shape.6 This technique is an evolution of the
Guilmet procedure, which we revisited, with some modifica-
tions, in the late 1990s and used until 2001.5 However, when
the scar is limited to the apical portion of the septum and the
anterior wall, a classic Dor procedure with or without a patch
will guarantee the maintenance of the conical shape because
it is applied to the distal part of the LV. The other peculiar
aspect of this disease is the progressive increase in MR inci-
dence: in group S 45.8% of the patients required mitral
valve surgery versus 22.4% in group V. Conventional goals
during reconstruction of the left ventricle in patients with is-
chemic heart disease and anteroseptal scars are directed to-
ward excluding scars. However, retention of the spherical
shape might persist when patch placement is limited to the
scar rim (see Figure 4 in Doenst and coworkers14); the result
is a smaller cavity and a more spherical heart. LV sphericity
can further progress in the months after surgical interven-
tion.15 Fluid dynamics in more spherical ventricles are im-
paired,14 and reduction of both volume and wall stress can
be insufficient to improve function.16 Our study shows
that when the shape is the goal of the LV surgery, results
are superior not only in the early term but also in the long
term. Need for a different surgical strategy is emphasized
by the results of the STITCH trial, hypothesis 2,7 which re-
ports the data from 1000 patients randomized for CABG
(n ¼ 499) or CABG and LVSR (n ¼ 501). This study failed
to show any benefit of LVSR when compared with similar
patients in whom only CABG was performed in terms of
mortality, both early and late, and heart failure hospitaliza-
tion. Both groups had equal improvement in Canadian Car-
diovascular Society angina class, in NYHA heart failure
class, in 6-minute walking test results, and, globally, in
symptoms. The surgical technique used was the classic
Dor operation,17,18 in which the purpose was to re-establish
a volume and not a shape. Strangely, the presence of a previ-The Journal of Thoracic and Carous acute myocardial infarction (AMI) was not a prerequisite
for study inclusion (13% of the patients in each group had
no AMI), and whether a previous AMI was Q-wave or no
Q-wave was not specified. Recently, Carluccio and col-
leagues19 showed that in patients with an EF of less than
40% and no evidence of transmural AMI, the presence of
hybernating myocardium could cause severe geometric mod-
ifications, which can mimic a septoapical scar (see Figure 5,
B, in Carluccio and colleagues19) but are reversible after
CABG alone. The success of LV remodeling surgery depends
on how it affects end-systolic pressure–volume (elastance)
and end-diastolic pressure–volume (compliance) relation-
ships and how these changes affect ventricular function
(stroke volume versus end-diastolic pressure [Starling] rela-
tionship).20 The effect of surgical intervention on the Starling
relationship remains unclear because many patients have
simultaneous CABG or CABG and mitral valve surgery.
This makes the clinical effect of LVSR on LV function im-
possible to interpret. Furthermore, diastolic function after
LVSR depends also on the amount of fibrous tissue present
in the remote area. Takeda and coworkers21 demonstrated
that the percentage of fibrosis detected with nuclear magnetic
resonance imaging correlated linearly with significantly
worse postoperative hemodynamic variables and LV function
recovery. Most of the patients in our recent experience (group
S) had akinetic rather than dyskinetic areas. Akinesia was
a risk factor in some reports; however, in our experience pa-
tients with akinetic anteroseptal segments had similar results
to patients with dyskinetic areas. A limit of any procedure that
aims for left ventricular reshaping is the preoperative diastolic
dimension of the base of the heart,22 a surrogate that reflects
changes toward sphericalization of the left ventricle. This re-
sults in change of the myofibril orientation from oblique to
transverse, and this disposition is caused by the loss of ellip-
tical shape and results in a diminished function, which in turn
causes more enlargement with deeper geometric (spherical)
consequence. When LVSR has to be abandoned in favor of
different treatments (LV mechanical support and heart trans-
plantation) is still matter of debate.diovascular Surgery c Volume 139, Number 5 1127
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This study has several limitations. It is a retrospective anal-
ysis of many patients undergoing operations over a long pe-
riod of time, when techniques, strategies, and experience
progressively increased and improved, and the retrospective
nature of this study causes, by definition, a selection bias.
Moreover, this article reports the evolution of a concept
across time, starting from the volume reduction toLV reshap-
ing, and therefore although its retrospective nature represents
a limitation, we believe that a retrospective study is the only
chance we had to report our experience. Being retrospective,
some preoperative data are missing (ie, wall motion data,
right ventricular function, description of any coronary lesion,
and conicity index) or incomplete, and therefore a complete
vision of the preoperative status of the patients was not pos-
sible in some cases. Furthermore, the echocardiographic as-
sessment was possible in only 45% of the patients. We were
not able to confirm that this new surgical technique resulted
in a different ventricle than the previous surgical technique
used by us late after surgical intervention because we did
not have a consistent echocardiographic follow-up.
Most descriptions of the effect of shape on function are
only experimental or rely on assumptions never validated
in human diseased hearts. The notion that myofibril orienta-
tion changes within a remote segment of myocardium with
the development of dilation in response to an anterior infarc-
tion has never been demonstrated in vivo.14CONCLUSION
Long-term results after LVSR are satisfying but in our ex-
perience seem to be better if a conical shape is rebuilt. The
designation of V and S groups represents different patient
groups, and the more recent group fared better than the early
group. Future studies will be required to determine whether
the attempt to reshape the ventricle was successful and influ-
enced the outcome. An unsolved question is how to establish
the limits of LVSR (eg, grade of preoperative diastolic dys-
function, diastolic diameter, ventricular volume, and func-
tion of the remote zone). The role of each treatment for the
single patient (medical treatment, CABG alone, and
CABG and LVSR) is still to be identified.References
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Dr Lorenzo A. Menicanti (Milan, Italy). I have no conflict of
interest.
I want to congratulate Antonio for this very interesting presenta-
tion. It is an important effort to improve our knowledge in a very
unique surgical field, particularly when the data of the STICH trial
have been published, raising a lot of discussion. Before consideringgery c May 2010
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surgical procedure named the Dor procedure. Considering this pro-
cedure, as it has been done in Antonio’s presentation, as simple vol-
umetric reduction is reductive and shows a limited knowledge of
the Dor procedure’s contribution. In the original article Dor pub-
lished in 1988, the procedure is described as ‘‘endoventricular cir-
cular patch plasty with septal exclusion.’’ The goal, as described in
this article, is exclusion of the septal akinetic segment, reorganizing
the remaining LV muscle without critically compromising the size
of the left ventricle. Therefore this technique deeply affects the sep-
tal reshaping. Today, a series of new techniques have been pub-
lished for surgical ventricular restoring, but the basic concept is
always the same as defined by Vincent Dor, even if people have
some difficulties admitting it.
In this article Dr Calafiore proposes a surgical technique to
preserve as much as possible an elliptical shape, and the results
are compared with those of a surgical technique defined as the stan-
dard Dor procedure. I have 3 questions for Antonio.
First, according to your procedure, the length of the patch
depends on the distance between the highest point and the new
apex. How do you select the position of the new apex when the
entire apical zone is involved in LV dilatation and the longitudinal
diameter is elongated?
Dr Calafiore. Thank you, Lorenzo, for your questions. In the
normal heart the longitudinal diameter is made by 2 parts. The first
one goes from the base of the heart to the base of the papillary mus-
cles; this part cannot be treated by means of surgical intervention.
The second part goes from the base of the papillary muscles to
the apex; this segment is approachable during surgical intervention.
In the normal heart the transverse diameter is roughly similar to
the distance from the base of the heart to the base of the papillary
muscle. The second distance is around 3 cm. When we have to
choose a new apex in patients with a transverse diameter larger
than normal, the new apex has to be positioned at least 5 cm
from the base of the papillary muscles, depending on the transverse
diameter and on the fixed part of the longitudinal diameter (base of
the heartbase of the papillary muscles). This allows us to maintain
an acceptable sphericity index. If the scar is near the papillary mus-
cle, the apex has to be in the scarred part. Then we need to include
the scar in the correction.
Dr Menicanti. Thank you. You conclude in your article that
a more physiologic elliptical shape improves the surgical results.
Unfortunately, as you say, the 2 groups of patients underwent
operations in 2 different periods. The 2 groups had the same base-
line volume, but the reduction of the volume was different; 30%
was the reduction in group S against only 20% in group V. The
EF increased in 17% in group S against 7 in group V. CABG
was performed in 73% of group S versus 9% of group V.The Journal of Thoracic and CarIt seems tome that the groupVpatients had amore diffuse disease
than the group S patients, in whom a more localized dilatation is
present with a better contractility in the remote zone. This can ex-
plain a good improvement of EF with fewer revascularizations.
Therefore the better result can be linked to a more important volume
reduction in the shape group. Can you comment on that?
Dr Calafiore. The volume reduction shown in the slides is the
volume reduction after roughly 5 years and not in the immediate
postoperative period. The difference in revascularization depends
on different surgical strategies. In the beginning, the left anterior
descending coronary artery was always grafted, even if the territory
was scarred. Today we never graft the left anterior descending
coronary artery if its territory is extensively scarred. The clinical
pattern of the patients we see today is worse than before because
the presence of akinetic areas with higher pulmonary pressures
reflects a clinical status in these patients that is worse than before.
In the past, surgical intervention was easier because the areas were
mainly dyskinetic. Today these patients are sicker than before
because the akinetic areas are predominant.
DrMenicanti. Finally, If the goal of the procedure is to exclude
all scars from the cavity, keeping a sphericity index in the normal
range, how do you avoid the risk of having too small a cavity at
the end of the procedure?
Dr Calafiore. The purpose of the correction is not to totally
eliminate the scar. You cannot completely eliminate the scar while
maintaining a conical heart. To avoid the excess or reduction of vol-
ume, we modify not the length of the patch, which depends on the
position of the new apex, but its height, which depends on the initial
end diastolic volume. In the presence of large end-diastolic vol-
umes (80 mL/m2), we use a patch with a length/height ratio of
3:1. If the end-diastolic volume is less than 80 mL/m2, we use
a larger patch with a ratio of 2:1. This strategy eliminates or reduces
at the maximum the possibility of a hypodiastolic syndrome.
Dr Menicanti. But this is determined by your experience?
Dr Calafiore. Of course.
Dr Menicanti. There are no rules?
Dr Calafiore. The only rule we follow is that the apex has to be
put in the scarred tissue to have a longitudinal diameter that is as
long as possible. Patients with apical akinesia can have a normal
life if the akinesia is concentrated just in the distal portion of the
left ventricle. We then prefer to have some scarring in the apex
rather than to eliminate all the scars but with the danger of having
a small cavity with a sphericity index that can approach 1.0.
Dr Menicanti. Do you think that is the approach with your
experience?
Dr Calafiore. I think so. I am not the only surgeon who is using
this technique.
Dr Menicanti. Thank you very much.diovascular Surgery c Volume 139, Number 5 1129
APPENDIX 1. Variables building the final propensity score model
Age
Female sex
Location of myocardial infarction
Angina
New York Heart Association class
Ejection fraction
End-systolic volume
Reoperation
Mitral regurgitation
Tricuspid regurgitation
Systolic pulmonary artery pressure
Mitral valve surgery
Tricuspid valve repair
Number of grafts
APPENDIX 2. Variables initially entered into the multivariable
models
Age (years)
Sex
Body mass index
Body surface area
New York Heart Association class
Heart failure
Angina
Chronic atrial fibrillation
Presence of diabetes
Presence of hypertension
Presence of hypercholesterolemia
The location of myocardial infarction
Presence of dyskinesis versus akinesis
Chronic obstructive pulmonary disease
Chronic renal failure
Extracardiac vasculopathy/previous stroke or transient ischemic attack
Left ventricular end-diastolic volume (mL/m2)
Left ventricular end-systolic volume (mL/m2)
Left ventricular ejection fraction (%)
Left ventricular end-diastolic sphericity index
Mitral regurgitation grade (from 0 to 4þ)
Tricuspid regurgitation grade (from 0 to 4þ)
Systolic pulmonary artery pressure (mm Hg)
Mitral valve surgery
Coronary artery bypass grafting
Tricuspid valve surgery
Surgical choice of volume reduction rather than reshaping
Reoperation
Cardiopulmonary bypass time (min)
Cross-clamping time (min)
Surgeon
Year of operation
Time interval (distance from follow-up to operation time in months)*
*Time interval was initially inserted into the longitudinal regression analyses (both
mixed and ordinal).
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